Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MTI-201 by Modulation Therapeutics for Metastatic Uveal Melanoma: Likelihood of Approval
MTI-201 is under clinical development by Modulation Therapeutics and currently in Phase I for Metastatic Uveal Melanoma. According to GlobalData,...
Data Insights
MTI-201 by Modulation Therapeutics for Metastatic Uveal Melanoma: Likelihood of Approval
MTI-201 is under clinical development by Modulation Therapeutics and currently in Phase I for Metastatic Uveal Melanoma. According to GlobalData,...